PGNY Progyny Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PGNY

Price (delayed)

$33.45

Market cap

$3.12B

P/E Ratio

101.36

Dividend/share

N/A

EPS

$0.33

Enterprise value

$3.01B

Progyny is a leading fertility benefits management company in the US. The company is redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously ...

Highlights
The revenue has surged by 57% year-on-year and by 12% since the previous quarter
PGNY's equity is up by 50% year-on-year and by 9% since the previous quarter
The EPS has dropped by 55% year-on-year and by 28% since the previous quarter
The net income has plunged by 54% YoY and by 28% from the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: http://www.progyny.com

Key stats

What are the main financial stats of PGNY
Market
Shares outstanding
93.38M
Market cap
$3.12B
Enterprise value
$3.01B
Valuations
Price to earnings (P/E)
101.36
Price to book (P/B)
8.24
Price to sales (P/S)
3.92
EV/EBIT
127.39
EV/EBITDA
119.31
EV/Sales
3.82
Earnings
Revenue
$786.91M
EBIT
$23.63M
EBITDA
$25.23M
Free cash flow
$77.15M
Per share
EPS
$0.33
Free cash flow per share
$0.84
Book value per share
$4.06
Revenue per share
$8.54
TBVPS
$5.76
Balance sheet
Total assets
$542.99M
Total liabilities
$166.02M
Debt
$6.48M
Equity
$376.97M
Working capital
$274.32M
Liquidity
Debt to equity
0.02
Current ratio
2.72
Quick ratio
2.69
Net debt/EBITDA
-4.5
Margins
EBITDA margin
3.2%
Gross margin
21.3%
Net margin
3.9%
Operating margin
3%
Efficiency
Return on assets
6.3%
Return on equity
9.2%
Return on invested capital
9.1%
Return on capital employed
6.2%
Return on sales
3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PGNY stock price

How has the Progyny stock price performed over time
Intraday
-0.15%
1 week
-1.21%
1 month
4.43%
1 year
-33.14%
YTD
7.38%
QTD
7.38%

Financial performance

How have Progyny's revenue and profit performed over time
Revenue
$786.91M
Gross profit
$167.33M
Operating income
$23.34M
Net income
$30.36M
Gross margin
21.3%
Net margin
3.9%
The company's net margin has shrunk by 70% YoY and by 35% QoQ
The revenue has surged by 57% year-on-year and by 12% since the previous quarter
The net income has plunged by 54% YoY and by 28% from the previous quarter
PGNY's operating margin has dropped by 54% year-on-year but it is up by 7% since the previous quarter

Growth

What is Progyny's growth rate over time

Valuation

What is Progyny stock price valuation
P/E
101.36
P/B
8.24
P/S
3.92
EV/EBIT
127.39
EV/EBITDA
119.31
EV/Sales
3.82
The EPS has dropped by 55% year-on-year and by 28% since the previous quarter
The stock's price to earnings (P/E) is 29% more than its last 4 quarters average of 78.7
PGNY's equity is up by 50% year-on-year and by 9% since the previous quarter
PGNY's price to book (P/B) is 23% lower than its last 4 quarters average of 10.7
The revenue has surged by 57% year-on-year and by 12% since the previous quarter
PGNY's price to sales (P/S) is 27% lower than its last 4 quarters average of 5.4

Efficiency

How efficient is Progyny business performance
The company's return on equity has shrunk by 70% YoY and by 35% QoQ
Progyny's return on assets has shrunk by 69% YoY and by 34% QoQ
PGNY's return on invested capital has dropped by 56% year-on-year but it is up by 10% since the previous quarter
The return on sales has dropped by 53% year-on-year but it has grown by 7% since the previous quarter

Dividends

What is PGNY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGNY.

Financial health

How did Progyny financials performed over time
PGNY's total liabilities has surged by 56% year-on-year
PGNY's total assets has soared by 52% YoY and by 6% from the previous quarter
The company's debt is 98% lower than its equity
PGNY's equity is up by 50% year-on-year and by 9% since the previous quarter
PGNY's debt to equity is down by 33% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.